Labiano-Almiñana, S. (., Laspidea, V. (., Garcia-Moure, M. (., Puigdelloses-Vallcorba, M. (., Becher, O. (. J., Gomez-Manzano, C. (., . . . Alonso-Roldán, M. (. M. (2021). The oncolytic virus delta-24-RGD in combination with an agonistic CD40 mAb induces a durable and synergistic anti-tumor immune effect in DIPG preclinical models.

Labiano-Almiñana, S. (Sara)|||/items/65de3442-2f0f-4c20-8e40-43525bb58657, V. (Virginia)|||/items/16d4f649-0742-47dc-a391-881d6cfb978f Laspidea, M. (Marc)|||/items/9741d07b-2525-4e98-9bfc-93fc3e869273 Garcia-Moure, M. (Montserrat)|||/items/658120d0-6a3c-4bf3-9446-33a9234f787e Puigdelloses-Vallcorba, O.J. (Oren J.)|||/items/8218a203-30af-4259-a7fc-91aa4e2c1faa Becher, C. (Candelaria)|||/items/5e8d7495-6be8-46e1-8303-cfd722d30166 Gomez-Manzano, J. (Juan)|||/items/a4e5ff79-2565-4461-ab26-34868ff5ff4d Fueyo, A. (Ana)|||/items/d68c74f1-df22-4e04-9b77-9cf48fd87b46 Patiño-García, y M.M. (Marta María)|||/items/b912e21e-f895-4efe-bc4c-de1ca8f36c37 Alonso-Roldán. The Oncolytic Virus Delta-24-RGD in Combination With an Agonistic CD40 MAb Induces a Durable and Synergistic Anti-tumor Immune Effect in DIPG Preclinical Models. 2021.

Labiano-Almiñana, S. (Sara)|||/items/65de3442-2f0f-4c20-8e40-43525bb58657, et al. The Oncolytic Virus Delta-24-RGD in Combination With an Agonistic CD40 MAb Induces a Durable and Synergistic Anti-tumor Immune Effect in DIPG Preclinical Models. 2021.